Tianzhi Zhao

3PUBLICATIONS
25CO-AUTHORS
BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 17, 2026
Albumin binding improves the pharmacokinetics and therapeutic efficacy of a 177Lu-labeled HER2 Fab radioconjugate.

|Feb 23, 2026
MSA-2 Loaded Three-Dimensional Metal Covalent Organic Framework for Synergistic Radiosensitization and Innate Immune Activation.

Wenyao Zhen, Wang-Kang Han, Tianzhi Zhao

|Oct 06, 2023
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study.

Hao Fu, Jingxiong Huang, Tianzhi Zhao

Pageof 1

Frequent Collaborators

3 joint publications

Xiaoyuan Chen

3 joint publications

Jingjing Zhang

2 joint publications

Yizhen Pang

2 joint publications

Wenyao Zhen